Technology Advancements to Limelight’s Orchestrate Platform Drive Unmatched Content Delivery Performance
Limelight Networks, Inc. (Nasdaq: LLNW), a global leader in digital content delivery, today announced that content can now be downloaded faster and viewers can stream videos at higher quality thanks to a major upgrade to its global infrastructure. The advancements deliver breakthrough improvements to performance, capacity, and efficiency.
Limelight has completed the global rollout of a new and enhanced version of its EdgePrism OS software that’s designed to optimize user experience for the fewest video rebuffers, lowest latency, highest throughput, and superior security. This new software helps boost Limelight’s edge server capacity by more than 120 percent by maximizing the performance of Limelight’s server hardware and application suite. As a result, content can be downloaded faster, and viewers can stream videos at higher quality while experiencing fewer rebuffers. Customer-provided real-world data shows a greater than 19% reduction in video sessions experiencing rebuffers.
Limelight’s global private QoS-enabled network includes more than 80 Points-of-Presence (PoPs) in over 40 metropolitan locations with 29+ terabits per-second of egress capacity interconnected with more than 900 major ISPs and last-mile networks. Unlike traditional CDN vendors that rely on third-party technologies for key components of their content delivery infrastructure, Limelight’s ongoing investment in the development and optimization of every component of its CDN provides industry-leading performance, even over congested or changing network conditions.
Other recent advancements and enhancements include:
- Faster Servers and Connectivity: Edge servers have been updated to the latest high-density 1U servers with solid state drives and 50 Gigabit Ethernet (GbE) network connectivity. This hardware update increases edge compute capacity and improves performance and cache management while reducing the number of servers deployed.
- New EdgePrism DNS: Limelight’s rules-based Domain Name System (DNS) now features intelligent Point-of-Presence (PoP) and server selection with real-time decision making that utilizes a constantly updated map of the internet to ensure optimal delivery performance and throughput for each customer request.
- 100 GbE Backbone Links: Core backbone links have been upgraded to 100 GbE, allowing cache-fill traffic, dynamic content, and integrated service data to bypass the congested public internet, resulting in faster, more reliable, and more secure content delivery.
- PoP Expansion: Global egress capacity has been expanded by more than 40 percent by adding 11 new PoPs and completing full upgrades of 20 additional PoPs to address growing market demand for CDN services.
“Even in emerging regions -- where viewers rely on older mobile networks for video streaming – Limelight is helping customers achieve their most important business objectives by improving the quality of experience they deliver to their viewers,” said Steve Miller-Jones, Senior Director of Product Management at Limelight Networks. “Our ongoing investments in our network and software are paying off, resulting in greater capacity, broader coverage, and increased network performance.”
The Limelight Orchestrate Platform is built on a global, private backbone network with the speed, capacity and availability to deliver the experiences today's audiences demand. The platform includes integrated content delivery, web acceleration, origin storage, video management, cloud security and support services. The unique combination of global private infrastructure, advanced software, and expert services surpasses other content delivery networks (CDNs), enabling today's and tomorrow's workflows and putting audience experiences first.
For more information on the Limelight Orchestrate Platform visit https://www.limelight.com/orchestrate-platform/.
About Limelight
Limelight Networks, a global leader in
digital content delivery, empowers customers to better engage online
audiences by enabling them to securely manage and globally deliver
digital content, on any device. The company’s Limelight Orchestrate
Platform includes a global infrastructure with a fully-integrated suite
of capabilities and services to help you address all your content
delivery needs. The Orchestrate Platform solves your most important
content delivery challenges so you can deliver the next great digital
experience anywhere. For more information, please visit www.limelight.com
and follow us on Twitter,
Facebook
and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180227005297/en/
Contact information
SHIFT Communications
Lori Niquette, 617-779-1800
Limelight@shiftcomm.com
or
Investor
Inquiries: ir@limelight.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Azafaros to Present at BIO International Convention 2025 Following Successful €132M Series B Financing9.6.2025 08:00:00 EEST | Press release
Azafaros, a clinical-stage biotechnology company developing novel therapies for rare lysosomal storage disorders (LSDs), today announced that it will present at the 2025 BIO International Convention taking place in Boston, USA, from 16-19 June. The company’s presentation is scheduled for Monday, June 16 at 16:45 ET in Room 153B. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses and Niemann-Pick disease type C (NPC). This announcement follows Azafaros’ recently completed and oversubscribed €132 million Series B financing round, which will support advancing nizubaglustat into pivotal clinical development. The company is on track to initiate two Phase 3 trials in GM1/GM2 gangliosidoses and NPC in 2025. Earlier this year, Azafaros reported positive topline results from its ongoing Phase 2 study evaluating n
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom